Taro Readies Branded OTC Exodus With ElixSure, Kerasal Divestiture
This article was originally published in The Tan Sheet
Executive Summary
Taro's divestiture of its ElixSure cough/cold medicine and Kerasal moisturizer brands in North America to Alterna signals the firm's exit from the branded OTC drug market
You may also be interested in...
ElixSure
Alterna extends its children's ElixSure line with spill-resistant formulations of ElixSure Liquid Allergy (diphenhydramine 12.5 mg) in bubble gum flavor and ElixSure EX Liquid Expectorant (guaifenesin 50 mg) in strawberry. The products come in 4 oz. bottles for $5.99 each, and will be available in early fall. The extensions add to the line's current formulations, which include Congestion (pseudoephedrine HCl), Cough (dextromethorphan HBr) and Fever/Pain. Alterna announced its acquisition of the ElixSure line from Taro Consumer in March (1"The Tan Sheet," March 7, 2005, p. 11)...
ElixSure
Alterna extends its children's ElixSure line with spill-resistant formulations of ElixSure Liquid Allergy (diphenhydramine 12.5 mg) in bubble gum flavor and ElixSure EX Liquid Expectorant (guaifenesin 50 mg) in strawberry. The products come in 4 oz. bottles for $5.99 each, and will be available in early fall. The extensions add to the line's current formulations, which include Congestion (pseudoephedrine HCl), Cough (dextromethorphan HBr) and Fever/Pain. Alterna announced its acquisition of the ElixSure line from Taro Consumer in March (1"The Tan Sheet," March 7, 2005, p. 11)...
ElixSure
Alterna extends its children's ElixSure line with spill-resistant formulations of ElixSure Liquid Allergy (diphenhydramine 12.5 mg) in bubble gum flavor and ElixSure EX Liquid Expectorant (guaifenesin 50 mg) in strawberry. The products come in 4 oz. bottles for $5.99 each, and will be available in early fall. The extensions add to the line's current formulations, which include Congestion (pseudoephedrine HCl), Cough (dextromethorphan HBr) and Fever/Pain. Alterna announced its acquisition of the ElixSure line from Taro Consumer in March (1"The Tan Sheet," March 7, 2005, p. 11)...